Page 36 - Annual report 2021-22
P. 36

Annual Report 2021-22 |






               Aastha Mishra

                                                                                                                  19


               Aastha Mishra’s lab works in the area of hypoxia adaptation.

               Hypoxia has been linked with inflammation and activation of many cells such as endothelium, platelets
               and  lymphocytes  causing  homeostatic  imbalance,  secretion  of  pro-thrombotic  and  antifibrinolytic
               factors. Her lab studies hypoxia induced thrombosis using a cellular model where human umbilical
               endothelial cell line (HUVEC) is exposed to thrombin and 1% oxygen environment. Hypoxia markers
               such as hypoxia inducible factor--1 alpha (HIF-1alpha), prolyl hydroxylase-1 (PHD2) and prothrombotic
               markers such as caspase 4, VCAM-1, E-selectin, P-selectin, Factor-2 were assessed for the validation
               of their hypoxia-induced in vitro thrombosis model. The markers were compared to the cells not
               subjected to thrombin or hypoxia. An induction of all these markers occurred due to hypoxia and
               thrombin exposure. Future studies aim to identify the role of HIF1alpha in this process. Findings from
               these studies will also be tested in high altitude exposed hypoxia.  Both cases and controls (lowlanders
               and highlanders) will be collected and demographic as well as clinical profiles will be carried out for
               each blood sample.

               Aastha’s work extends to understand the interplay between unfolded protein response (UPR) and
               inflammatory pathways in hypoxia-induced thromboembolic disorders. Hypoxia is a condition in which
               oxygen level in the cells or tissues decreases leading to activation of HIF-1 alpha, reactive oxygen
               species (ROS) and inflammation. These factors contribute to endothelial cell dysfunction, activation
               and an imbalance between  procoagulant and anticoagulant proteins. All these pathophysiological
               conditions in the body can lead to thrombosis. Thrombosis is a complex process of formation of blood
               clots inside blood vessels leading to obstruction in blood flow. Additionally, hypoxia also contributes
               to  the  accumulation  of  misfolded  proteins  in  endoplasmic  reticulum  (ER)  lumen  because  of
               disturbance  in  oxidative  protein  folding  leading  to  ER  stress.  Activation  of  chronic  UPR  leads  to
               endothelial cell dysfunction, a crucial feature of hypoxia induced thrombosis. Her group has found
               induction of the UPR in the cellular model of hypoxia and thrombin exposure. Further studies will be
               aimed at understanding the role of the inflammatory response on the induction of UPR.
   31   32   33   34   35   36   37   38   39   40   41